CHEMOS
SM-102

SM-102

Nom chimique

heptadecan-9-yl 8-[2-hydroxyethyl-(6-oxo-6-undecoxyhexyl)amino]octanoate

SM-102•LNP
Structure: SM-102 structure, CAS 2089251-47-6, MW 710.17
N° produit
CH51018
CAS
2089251-47-6
FM
C44H87NO5
PM
710.17
Spécification
Catalog No.CH51018
CAS No.2089251-47-6
Molecular FormulaC44H87NO5
Molecular Weight710.17

CHEMOS Support for This Category

CHEMOS supports custom synthesis and process development for LNP lipid components, with work planned according to target structure, requested scale, and analytical requirements. Ionizable lipid route development : route scouting, impurity review, stereochemistry control, and purification planning. Helper lipid and PEG-lipid preparation : support for phospholipids, sterol-related components, PEG-lipids, and related analogs. Analytical support : HPLC, NMR, MS, Karl Fischer water content, elemental analysis, and residual-solvent testing can be discussed by project. Scale-up support : transfer from laboratory preparation to larger pilot or production batches after route and quality review. Project documentation : batch-specific COA and technical information are provided according to the confirmed specification.

Vue d’ensemble

SM-102 (also known as heptadecan-9-yl 8-[2-hydroxyethyl-(6-oxo-6-undecoxyhexyl)amino]octanoate) (CAS 2089251-47-6, MF C44H87NO5, MW 710.17) is an ionizable cationic lipid analog used in LNP formulation research. Common chemistry questions involve scalable preparation of the lipid backbone, analog screening, and impurity control across batches. CHEMOS process-development team and large production base can support route refinement, scale-up and custom synthesis on request.

Applications

  • SM-102 (2089251-47-6) supply and analog preparation for research programs
  • Lipid nanoparticle (LNP) formulation research for mRNA / siRNA delivery
  • Process-development support for scalable ionizable lipid preparation
  • Reference comparator in next-generation ionizable lipid programs

Besoin d’une synthèse à façon ?

Notre équipe CDMO accompagne la synthèse à façon, de l’évaluation de voie au développement de procédé et au scale-up.

Voir les services CDMO